Följ
Thierry Kogej
Thierry Kogej
Associate Principal Scientist, AstraZeneca
Verifierad e-postadress på astrazeneca.com
Titel
Citeras av
Citeras av
År
Design of organic molecules with large two-photon absorption cross sections
M Albota, D Beljonne, JL Brédas, JE Ehrlich, JY Fu, AA Heikal, SE Hess, ...
Science 281 (5383), 1653-1656, 1998
26331998
Generating focused molecule libraries for drug discovery with recurrent neural networks
MHS Segler, T Kogej, C Tyrchan, MP Waller
ACS central science 4 (1), 120-131, 2017
9402017
Mechanisms for enhancement of two-photon absorption in donor–acceptor conjugated chromophores
T Kogej, D Beljonne, F Meyers, JW Perry, SR Marder, JL Brédas
Chemical Physics Letters 298 (1-3), 1-6, 1998
3971998
Designing novel building blocks is an overlooked strategy to improve compound quality
FW Goldberg, JG Kettle, T Kogej, MWD Perry, NP Tomkinson
Drug Discovery Today 20 (1), 11-17, 2015
1652015
Tuning the two-photon absorption response of quadrupolar organic molecules
E Zojer, D Beljonne, T Kogej, H Vogel, SR Marder, JW Perry, JL Bredas
The Journal of chemical physics 116 (9), 3646-3658, 2002
1522002
ChemGPS-NPWeb: chemical space navigation online
J Rosén, A Lövgren, T Kogej, S Muresan, J Gottfries, A Backlund
Journal of computer-aided molecular design 23 (4), 253-259, 2009
1052009
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
S Muresan, P Petrov, C Southan, MJ Kjellberg, T Kogej, C Tyrchan, ...
Drug Discovery Today 16 (23-24), 1019-1030, 2011
842011
Science1998, 281, 1653
M Albota, D Beljonne, JL Brédas, JE Ehrlich, JY Fu, AA Heikal, SE Hess, ...
Google Scholar There is no corresponding record for this reference, 0
78
Multifingerprint based similarity searches for targeted class compound selection
T Kogej, O Engkvist, N Blomberg, S Muresan
Journal of chemical information and modeling 46 (3), 1201-1213, 2006
752006
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca–Bayer Pharma AG case
T Kogej, N Blomberg, PJ Greasley, S Mundt, MJ Vainio, J Schamberger, ...
Drug discovery today 18 (19-20), 1014-1024, 2013
742013
Secondary metabolites from cetrarioid lichens: Chemotaxonomy, biological activities and pharmaceutical potential
M Xu, S Heidmarsson, ES Olafsdottir, R Buonfiglio, T Kogej, S Omarsdottir
Phytomedicine 23 (5), 441-459, 2016
712016
Datasets and their influence on the development of computer assisted synthesis planning tools in the pharmaceutical domain
A Thakkar, T Kogej, JL Reymond, O Engkvist, EJ Bjerrum
Chemical science 11 (1), 154-168, 2020
652020
Comparison of molecular fingerprint methods on the basis of biological profile data
A Steffen, T Kogej, C Tyrchan, O Engkvist
Journal of chemical information and modeling 49 (2), 338-347, 2009
652009
Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists
C Pégurier, P Collart, P Danhaive, S Defays, M Gillard, F Gilson, T Kogej, ...
Bioorganic & medicinal chemistry letters 17 (15), 4228-4231, 2007
482007
Science1998, 281, 1653− 1656
M Albota, D Beljonne, JL Bredas, JE Ehrlich, JY Fu, AA Heikal, SE Hess, ...
Google Scholar There is no corresponding record for this reference, 0
40
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds
C Tyrchan, N Blomberg, O Engkvist, T Kogej, S Muresan
Bioorganic & medicinal chemistry letters 19 (24), 6943-6947, 2009
392009
Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives
T Ryckmans, O Berton, R Grimée, T Kogej, Y Lamberty, P Pasau, ...
Bioorganic & medicinal chemistry letters 12 (21), 3195-3198, 2002
382002
Applications of deep-learning in exploiting large-scale and heterogeneous compound data in industrial pharmaceutical research
L David, J Arús-Pous, J Karlsson, O Engkvist, EJ Bjerrum, T Kogej, ...
Frontiers in pharmacology 10, 1303, 2019
342019
Scaffold hopping by fragment replacement
MJ Vainio, T Kogej, F Raubacher, J Sadowski
Journal of chemical information and modeling 53 (7), 1825-1835, 2013
342013
Exploring in silico prediction of the unbound brain-to-plasma drug concentration ratio: model validation, renewal, and interpretation
S Varadharajan, S Winiwarter, L Carlsson, O Engkvist, A Anantha, ...
Journal of Pharmaceutical Sciences 104 (3), 1197-1206, 2015
302015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20